Nuseed Eyeing APAC Extention for Omega-3 Canola OilThursday, July 26, 2018
Australian omega-3 canola oil firm Nuseed has applied for regulatory approval for its product in the US and Canada, and has outlined plans for its expansion across APAC, FoodNavigator-Asia reported last week. The company’s proprietary omega-3 canola oil sold under the human nutrition brand Nutriterra was developed by the Commonwealth Scientific and Industrial Research Organization (CSIRO) and Aussie agricultural chemical firm Nufarm (of which Nuseed is a subsidiary). Genetically engineered to contain convert oleic acid to DHA, the canola oil is meant to be sustainable alternative to fish oil.
Specifically, Nuseed wants to obtain non-regulated status for its canola oil, and to this end, has provided information from field trials and laboratory analyses that the product will not be a plant pest and as such, should not fall under Animal and Plant Health Inspection Service (APHIS) regulations. Nuseed has commenced clinical trial work in North America to further demonstrate the safety and efficacy of its canola oil, and to clinically support its marketing claims so as to strengthen its entry into the world’s largest supplement and fortified food market. The company hopes to gain approval for both consumption and cultivation of the canola oil by 2019.
Apart from Australia and North America, Nuseed has set its sights on Asia Pacific, where it expects approvals between 2021 and 2023, with more to follow in 2024 and beyond. From 2021 to 2023, the firm is aiming to achieve regulatory approval in China, Japan and South Korea, as well as throughout South East Asia, particularly in Vietnam, Thailand, the Philippines, and Indonesia.